Why SAIC Stock Is Down Today

Science Applications International (SAIC) reported fiscal Q2 EPS of $3.63, exceeding estimates, though largely attributable to one-time items, while revenue of $1.77 billion missed consensus and was down 3% year-over-year. Citing slower government bookings and delays in new business awards, the defense contractor cut its fiscal 2026 and 2027 EBITDA guidance, sending shares down 7%. CEO Toni Townes-Whitley noted a "more challenging revenue environment" but indicated potential upside if transaction flows normalize from current "prudent" assumptions.

Analysis

Science Applications International (SAIC) reported a mixed fiscal second quarter, characterized by a significant earnings per share beat that was heavily skewed by non-operational factors. The reported $3.63 EPS surpassed the $2.24 consensus estimate primarily due to approximately $1.10 per share from one-time items, including lower tax expenses and legal benefits, which masks underlying weakness. More concerning for the company's fundamental health, revenue declined 3% year-over-year to $1.77 billion, missing the $1.86 billion forecast, and bookings also fell short of expectations. Consequently, management has lowered its EBITDA guidance for fiscal years 2026 and 2027, citing a "more challenging revenue environment" driven by slower on-contract growth and delays in new government business awards. The market reacted negatively, with shares falling 7%, reflecting investor concerns over the deteriorating forward-looking outlook despite the CEO's characterization of the revised guidance as "prudent."

Key Decisions for Investors

• Investors should look past the headline EPS beat, as it was driven by one-time items, and instead focus on the more telling indicators of revenue decline and the downward revision of FY26 and FY27 EBITDA guidance.
• Given the stated headwinds from slower government contract awards, it is prudent to monitor SAIC's future booking rates and management commentary on transaction flows before considering new positions, as the current guidance assumes no near-term improvement.
• The 7% share price decline reflects significant uncertainty, and despite the company's stable long-term business model, the lack of visibility on revenue growth suggests caution is warranted over initiating or adding to positions at this time.